Intercept to Present at Upcoming Investor Conferences
November 11 2021 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat progressive
non-viral liver diseases, today announced that Jerry Durso,
President and Chief Executive Officer of Intercept; M. Michelle
Berrey, M.D., M.P.H., President of Research & Development and
Chief Medical Officer of Intercept; Linda Richardson, Chief
Commercial Officer of Intercept; and Andrew Saik, Chief Financial
Officer of Intercept, will participate virtually in fireside chats
at the following upcoming investor conferences:
- The 2021 Jefferies London Healthcare
Conference, for which the pre-recorded chat will be made available
on November 18, 2021;
- The Piper Sandler 33rd Annual
Virtual Healthcare Conference, for which the pre-recorded chat will
be made available on November 22, 2021.
The presentations can be accessed on the
investor page of Intercept’s website
at http://ir.interceptpharma.com, and an audio archive of the
pre-recorded chats will also be available on Intercept’s website
for approximately two weeks from the time they are made
available.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept
has operations in the United
States, Europe and Canada. For more information,
please visit www.interceptpharma.com or connect with the
company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Aug 2023 to Aug 2024